POLYPEPTIDE GROUP AG/ CH1110760852 /
| - - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| -USD | - | 995 Turnover: - |
-Bid Size: - | -Ask Size: - | 1.16 bill.USD | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -1.56 EUR | -750.00% |
| EPS Diluted: | - EUR | - |
| Revenues per Share: | 9.81 EUR | 14.60% |
| Book Value per Share: | 11.56 EUR | -9.20% |
| Cash Flow per Share: | 1.10 EUR | 129.11% |
| Dividend per Share: | - EUR | - |
| Total | in mill. | |
| Revenues: | 324.85 EUR | 14.60% |
| Net Income: | -51.44 EUR | -762.29% |
| Operating Cash Flow: | 36.49 EUR | - |
| Cash and Cash Equivalents: | 95.71 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | 3.34 | 1.91 |
| P/BV ratio: | 2.83 | 1.62 |
| P/CF Ratio: | 29.75 | 17.03 |
| PEG: | 0.03 | - |
| Earnings Yield: | -4.76% | -8.32% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 1.16 bill. USD | 686.56 mill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | 961,804.8298 USD | 571,185.3880 USD |
| Shares Outstanding: | 33.13 mill. | |
Profitability
| Gross Profit Margin: | 2.81% |
| EBIT Margin: | -11.23% |
| Net Profit Margin: | -15.83% |
| Return on Equity: | -13.44% |
| Return on Assets: | -7.46% |
Financial Strength
| Liquidity I / Cash Ratio: | 54.24% |
| Liquidity II / Quick Ratio: | 97.69% |
| Liquidity III / Current Ratio: | 185.10% |
| Debt / Equity Ratio: | 79.98% |
| Dynam. Debt / Equity Ratio: | 839.29% |
Efficiency
| Employees: | 1,202 |
| Personal Expenses / Employee: | - EUR |
| Revenues / Employee: | 270,260.40 EUR |
| Net Income / Employee: | -42,795.34 EUR |
| Total Assets / Employee: | 573,284.53 EUR |
| * Fiscal Year End: | 31/12/2023 |
| Accounting Standard: | IFRS |
| Currency: | EUR |
